What is Compugen Ltd. (CGEN)?
Compugen Ltd. is a biotechnology company engaged in the discovery and development of novel therapeutic candidates. The company utilizes computational biology and bioinformatics platforms to identify potential drug targets and biomarkers, focusing on immuno-oncology and other therapeutic areas. Compugen Ltd. integrates computational predictions with experimental validation to advance its pipeline of drug candidates. The company collaborates with pharmaceutical and biotechnology partners to develop and commercialize therapies. Its research efforts emphasize the modulation of immune system components to treat cancer and other diseases. Compugen Ltd. combines proprietary algorithms and data analysis techniques to enhance drug discovery processes. The company's approach aims to accelerate the identification of effective treatments by leveraging computational tools alongside traditional laboratory methods.
Compugen Ltd. Stock Price Today: Live Overview
The price today is shaped by trading activity in Compugen Ltd., where Compugen Ltd. - Ordinary Shares is at $2.2454. The price has oscillated between $2.2046 and $2.3446, with a percentage shift of 0%.
FAQ: Compugen Ltd. (CGEN)
What is the current price of CGEN stock?
The latest trading price is $2.2454.
Does CGEN pay dividends?
Compugen Ltd. does not currently pay dividends.
Does CGEN have a formal corporate presence or regional headquarters in the UAE?
Compugen Ltd. operates in the UAE through partnerships and distributors without an official office.
What is CGEN best known for?
Compugen Ltd. is most famous for its computational drug discovery platform.
What assets are typically shown together with CGEN?
Commonly shown alongside CGEN: Paradigm Biopharmaceuticals Limited, Neurocrine, Millicom International Cellular SA
Latest shares articles



